The West Virginia Office of Medical Cannabis (OMC) has issued a new technical advisory that redefines how strain names are regulated. Previously, strain names were not considered part of product labeling. Now, they are being scrutinized under strict packaging rules - prohibiting names that resemble food, candy, alcohol, or anything deemed inappropriate for a medical product by the OMC’s subjective and opaque standards.

Why This Matters:

Patients were excluded: There was no effort to include patient voices, even though these changes affect how they identify and access products.

Transparency is at risk: The new rules could limit the use of familiar strain names, making it harder for patients to understand what they’re purchasing.

Missed opportunity for feedback: Many stakeholders who would have submitted comments were left out and now may not have a say in the final guidance.

While it may be too late for the OMC to listen, the Medical Cannabis Advisory Board has a meeting on September 26th at 1PM.

They will be accepting comments through at least Monday August 25th. Send in your feedback to medcanwv@wv.gov

Here is a sample comment you can submit if you need a starting point:

“Subject: Patient Comment on TA #25010002 - Strain Name Guidance

As a medical cannabis patient, I’m concerned about the new guidance restricting strain names. Familiar strain names help me identify products that work for my condition and allow me to make informed decisions. Removing or changing these names without patient input risks confusion and limits transparency.

I respectfully ask that patients be included in future discussions and that the advisory consider how these changes affect our ability to access consistent, recognizable medicine.

Thank you for your consideration.

Sincerely,
[Patient Name/optional]”